We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TTNP market cap is 5.11M. The company's latest EPS is USD -0.6797 and P/E is -0.50.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 149k | 95k | 121k | 98k | 83k |
| Operating Income | -2.44M | -2.64M | -2.61M | -1.7M | -1.59M |
| Net Income | -2.46M | -2.64M | -2.57M | -1.68M | -1.59M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.62M | 3.61M | 4.84M | 1.53M | 557k |
| Operating Income | -8.26M | -16.84M | -7.35M | -9.35M | -10.24M |
| Net Income | -9.31M | -16.46M | -18.24M | -8.78M | -10.21M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.32M | 6.28M | 4.06M | 2.17M | 812k |
| Total Liabilities | 2.65M | 2.73M | 2.7M | 2.48M | 1.85M |
| Total Equity | 5.67M | 3.55M | 1.36M | -312k | -1.03M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.1M | 9.52M | 8.09M | 7.99M | 4.06M |
| Total Liabilities | 7.26M | 8.09M | 4.56M | 2.86M | 2.7M |
| Total Equity | 6.83M | 1.43M | 3.53M | 5.14M | 1.36M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.73M | -6.6M | -8.18M | -1.9M | -3.01M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.98M | 4.98M | 4.98M | N/A | N/A |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.43M | -15.45M | -17.2M | -7.9M | -8.18M |
| Investing | -416k | -256k | -540k | -23k | N/A |
| Financing | 10.62M | 11.77M | 17.93M | 8.84M | 4.98M |
| Market Cap | 5.11M |
| Price to Earnings Ratio | -0.50 |
| Price to Sales Ratio | 9.16 |
| Price to Cash Ratio | 1.74 |
| Price to Book Ratio | 3.75 |
| Dividend Yield | - |
| Shares Outstanding | 15.02M |
| Average Volume (1 week) | 11.38k |
| Average Volume (1 Month) | 22k |
| 52 Week Change | -63.62% |
| 52 Week High | 1.094 |
| 52 Week Low | 0.31 |
| Spread (Intraday) | 0.01 (2.86%) |
| Company Name | Titan Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.titanpharm.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
